Search Within

Heiko Schoder

  1. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (16)
  3. Research Letter (1)
Groups
  1. Bone Marrow Transplant (36)
  2. Center for Hematologic Malignancies (36)
  3. Department of Medicine (36)
  4. Hematologic Malignancies, Division of (36)
  5. Molecular Imaging and Therapy Service (36)
  6. Radiology, Department of (36)

More Groups

People
  1. Maria Palomba (25)
  2. Miguel-Angel Perales (24)
  3. Craig Sauter (20)
  4. Gunjan Shah (20)
  5. Joachim Yahalom (17)
  6. Andrew Zelenetz (16)

More People

Years
  1. 2025 (3)
  2. 2024 (3)
  3. 2023 (6)
  4. 2022 (3)
  5. 2021 (2)
  6. 2020 (3)

More Years

Publications
  1. Blood (15)
  2. Hematological Oncology (4)
  3. Bone Marrow Transplantation (2)
  4. International Journal of Radiation Oncology, Biology, Physics (2)
  5. Leukemia and Lymphoma (2)
  6. Blood Advances (1)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. Nature Publishing Group (4)
  3. Wiley Blackwell (4)
  4. Elsevier Inc. (3)
  5. Taylor & Francis Group (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (36)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T‐cell therapy outcome
    Meeting Abstract

    Imber, B. S.; Silverman, E. A.; Leithner, D.; Hubbeling, H.; Shah, G. L.; Fregonese, B.; Sanin, B. W.; Tomas, A. A.; Parascondola, A.; Saldia, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Immune signature of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Ganesan, N.; Shah, G. L.; Wong, P.; Argyropoulos, K. V.; Sen, F.; Dogan, A.; Straus, D. J.; Noy, A.; Kumar, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Correlative biomarkers for CART19 response in patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Batlevi, C. L.; Nos, G.; Kotlov, N.; Sorokina, M.; Okwali, M.; Bagaev, A.; Michaud, L.; Shah, G. L.; Shouval, R.; Tomas, A. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Patterns of relapse and risk reduction following tumor debulking by bridging radiotherapy prior to chimeric antigen receptor T cell therapy in non-Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Michaud, L.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Alarcon Tomas, A.; Shouval, R.; Palomba, M. L.; Batlevi, C. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Outcomes of adult T-cell leukemia/lymphoma with allogeneic stem cell transplantation: Single-institution experience
    Journal Article

    Epstein-Peterson, Z. D.; Ganesan, N.; Barker, J. N.; Drullinsky, P. R.; Ghione, P.; Jakubowski, A. A.; Kumar, A.; Moskowitz, A. J.; Noy, A.; Perales, M. A.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Phase II study of pembrolizumab plus GVD as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Hancock, H.; Davey, T.; Sohail, S.; Santarosa, A.; Pomerantz, L.; Jarjies, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Impact of allogeneic hematopoietic cell transplantation on immune evasive mechanisms in relapsed refractory large B-cell lymphoma
    Research Letter

    Lin, R. J.; Ho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Shah, G. L.; Perales, M. A.; Dahi, P. B.; Giralt, S. A.; Scordo, M.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patients
    Journal Article

    Lin, R. J.; Michaud, L.; Lobaugh, S. M.; Nakajima, R.; Mauguen, A.; Elko, T. A.; Ruiz, J. D.; Maloy, M. A.; Sauter, C. S.; Dahi, P. B.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save